CSMD1 and neoplasm: CSMD1, a regulator of complement activation and inflammation, has been proposed as a tumor suppressor gene in advanced oral, gastric, prostate and breast cancer and subsequent loss of CSMD1 functionality is associated to poor prognosis and enhanced proliferation, migration and invasion71–74.